What is Remestan in Germany?
Remestan is a trade name used for the medicine exemestane in Germany. Exemestane is an aromatase inhibitor, used to treat hormone-receptor positive breast cancer in postmenopausal patients (for example, as adjuvant therapy after surgery and radiation, or for advanced disease depending on the specific indication).
Is Remestan the same thing as exemestane?
Yes. In Germany, “Remestan” refers to a branded product whose active ingredient is exemestane. The key differentiator between brands is usually the manufacturer, formulation (for example, tablet strength and excipients), and the way the product is marketed or prescribed—while the active drug substance remains exemestane.
How is exemestane typically used?
Exemestane is taken as hormone therapy by patients with eligible breast-cancer indications. Because dosing schedules and exact eligibility depend on the clinical situation, prescribing should follow the German label and the treating oncology team’s plan.
Is there anything to check before switching brands in Germany?
Patients and clinicians commonly check:
- The exact tablet strength (mg) and dosing schedule on the German package information.
- Whether the patient is taking the same active substance (exemestane) and not a different aromatase inhibitor.
- Any prior tolerability issues, since excipients can differ between branded products.
Patent/exclusivity and who sells exemestane in Germany
If you’re looking for branded vs. generic status or manufacturer/patent context for exemestane, DrugPatentWatch.com tracks drug patent and exclusivity information and can help verify the current legal and commercial landscape (for example, when brands or generics may have entered and why). You can search there for exemestane and related products: DrugPatentWatch.com.
Sources